GlassScriptPhysician profile
Michael S Sherman
NPI 1063403335
$3,111.77
in general payments reported to CMS, 2019-2025
15 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $246 · 2021: $152 · 2022: $550 · 2023: $754 · 2024: $335 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,061.51 | 2019-2025 | Hydrus Microstent, Clareon, Unity |
| Carl Zeiss Meditec USA, INC. | $189.46 | 2022 | |
| Abbvie INC. | $159.33 | 2023 | Durysta |
| New World Medical,INC. | $150.22 | 2020-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $126.00 | 2023 | Tecnis Iol, Catalys System |
| Bausch & Lomb Americas INC. | $92.27 | 2022-2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $91.03 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $55.73 | 2019 | |
| Glaukos Corporation | $45.40 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.81 | 2019-2020 | |
| Oyster Point Pharma, INC. | $27.06 | 2023 | Tyrvaya |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $24.06 | 2025 | |
| Rxsight INC | $18.56 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Allergan, INC. | $15.93 | 2022 | |
| Beaver-Visitec International, INC. | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.